ADMA Biologics Inc (ADMA)
Net profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | -28,239 | -65,904 | -71,648 | -75,749 | -48,279 |
| Revenue | US$ in thousands | 258,215 | 154,080 | 80,943 | 42,220 | 29,349 |
| Net profit margin | -10.94% | -42.77% | -88.52% | -179.41% | -164.50% |
December 31, 2023 calculation
Net profit margin = Net income ÷ Revenue
= $-28,239K ÷ $258,215K
= -10.94%
ADMA Biologics Inc's net profit margin has shown improvement over the past five years. The company's performance, as indicated by its net profit margin, has gradually moved from negative territory in 2019 and 2020 to a less negative position in 2021, and then further improved in 2022 and 2023. Despite still having negative net profit margins in recent years, the trend suggests a positive direction in the company's ability to generate profits relative to its revenue. It is important for ADMA Biologics Inc to continue working towards achieving positive net profit margins in the future to demonstrate sustained financial health and efficiency in managing costs.
Peer comparison
Dec 31, 2023